Published online December 1, 2006
PEDIATRICS Vol. 118 No. 6 December 2006, pp. e1822-e1830 (doi:10.1542/peds.2005-2673)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fu, L. Y.
Right arrow Articles by Hibberd, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fu, L. Y.
Right arrow Articles by Hibberd, P.
Related Collections
Right arrow Infectious Disease & Immunity
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

ARTICLE

Brief Hospitalization and Pulse Oximetry for Predicting Amoxicillin Treatment Failure in Children with Severe Pneumonia

Linda Y. Fu, MD, MSca, Robin Ruthazer, MPHb, Ira Wilson, MD, MScb, Archana Patel, MD, DNB, MSCEc, LeAnne M. Fox, MD, MPHd, Tran Anh Tuan, MD, MSce, Prakash Jeena, MBChB, FCPf, Noel Chisaka, MBChB, MScg, Mumtaz Hassan, MBBS, FRCPh, Juan Lozano, MD, MSci, I Maulen-Radovan, MDj, Donald M. Thea, MD, MScd, Shamim Qazi, MB, BS, DSH, MSc, MDk and Patricia Hibberd, MD, PhDb

a Department of General and Community Pediatrics, Children's National Medical Center, Washington, DC
b Institute for Clinical Research and Health Policy Studies, Tufts-New England Medical Center, Boston, Massachusetts
c Clinical Epidemiology Unit, Indira Gandhi Medical Center, Nagpur, India
d Center for International Health, Boston University, Boston, Massachusetts
e Respiratory Department, Children's Hospital 1, Ho Chi Min City, Vietnam
f Paediatrics Department, Nelson R. Mandela School of Medicine, University of Kwazulu-Natal, Durban
g Department of Clinical Medicine, Tropical Disease Research Centre, Ndola, Zambia
h Department of Pediatrics, Children's Hospital, Islamabad, Pakistan
i Department of Pediatrics, Javeriana University School of Medicine, Bogotá, Columbia
j Pediatrics Department, Hospital Angeles Lomas, Mexico City, Mexico
k World Health Organization, Geneva, Switzerland

OBJECTIVE. In settings with limited assessment tools, we sought to determine whether early clinical signs and symptoms and blood oxygen saturation would predict amoxicillin treatment failure in children with severe pneumonia (as defined by the World Health Organization).

METHODS. Data were from a previously reported, multinational trial of orally administered amoxicillin versus injectable penicillin for the treatment of World Health Organization–defined severe pneumonia in children 3 to 59 months of age. We assessed all 857 participants assigned randomly to the experimental amoxicillin arm. Six multivariate logistic regression models were created and evaluated for their ability to predict failure after 48 hours of therapy. Regression models included vital signs, symptoms, and laboratory data collected at baseline and after 12 or 24 hours of observation. Oxygen saturation data were included in 3 models.

RESULTS. Clinical treatment failure occurred for 18% of children. Younger age, increased initial respiratory rate, and baseline hypoxia predicted treatment failure in all models. Data available after 24 hours improved the ability to predict failure compared with data available at baseline or 12 hours. The inclusion of oximetry data improved the predictive ability at baseline, 12 hours, and 24 hours. The ability to predict failure after 12 hours of observation with oximetry data was similar to the predictive ability after 24 hours without pulse oximetry data.

CONCLUSIONS. Assessment of clinical parameters at presentation and after 24 hours improved the ability to predict clinical failure of oral amoxicillin therapy, compared with assessment at presentation alone or at presentation and after only 12 hours, for children with World Health Organization–defined severe pneumonia.


Key Words: amoxicillin • pneumonia • hospitalization • oximetry • child

Abbreviations: ARI—acute respiratory infection • LCI—lower chest wall indrawing • RSV—respiratory syncytial virus • WHO—World Health Organization • CI—confidence interval


Accepted Jul 11, 2006.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
BMJHome page
Z. A Bhutta
Managing severe pneumonia in children in developing countries
BMJ, January 12, 2008; 336(7635): 57 - 58.
[Full Text] [PDF]